Literature DB >> 22634952

[Biological fragility syndrome in the elderly: systematic review].

Sheilla Tribess1, Ricardo Jacó de Oliveira.   

Abstract

OBJECTIVE: The aim of this study was to identify the prevalence and assessment strategies of Biological Fragility Syndrome in the Elderly.
METHODS: For the development of this study was it was done a search in electronic databases (Medline/PubMed) and the reference lists of articles identified using the following key words/terms in English: "frailty" and `frail" in conjunction with the terms "elderly", "aging" and "prevalence". These terms/descriptors were combined using the logical operators available in search engines. The initial electronic search resulted in 1 865 manuscripts. The process of analysis of the studies involved reading titles, abstracts and full texts. After all these phases, 35 manuscripts met the inclusion criteria of the review.
RESULTS: The results indicated that women, with rage from 7.3 % to 21.6 %, are frailer than men, with percentages ranging from 4 % to 19.2 %.
CONCLUSIONS: Differences in prevalence rates of prefrailty and frailty should be minimized, with stimulus for standardization for the evaluation of human frailty.

Entities:  

Mesh:

Year:  2011        PMID: 22634952     DOI: 10.1590/s0124-00642011000500014

Source DB:  PubMed          Journal:  Rev Salud Publica (Bogota)        ISSN: 0124-0064


  2 in total

1.  Pre-frailty and frailty of elderly residents in a municipality with a low Human Development Index.

Authors:  Wanderley Matos Reis Júnior; José Ailton Oliveira Carneiro; Raildo da Silva Coqueiro; Kleyton Trindade Santos; Marcos Henrique Fernandes
Journal:  Rev Lat Am Enfermagem       Date:  2014 Jul-Aug

Review 2.  Mapping instruments for assessing and stratifying frailty among community-dwelling older people: a scoping review.

Authors:  Luiz Eduardo Lima Andrade; Beatriz Souza de Albuquerque Cacique New York; Rafaella Silva Dos Santos Aguiar Gonçalves; Sabrina Gabrielle Gomes Fernandes; Álvaro Campos Cavalcanti Maciel
Journal:  BMJ Open       Date:  2021-12-22       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.